RYBP and glioblastoma: In fact, several studies have shown that the expression of RYBP is dysregulated in various human tumor tissues, including prostate [75,76], lung [77], liver, breast, hepatocellular carcinoma, glioblastoma [78], Hodgkin lymphoma, and cervical cancer [17,19,79,80,81,82,83].